| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14767058.2017.1319923 |
| P698 | PubMed publication ID | 28412848 |
| P50 | author | Laura E Martínez-Garza | Q57364332 |
| P2093 | author name string | Carlos Horacio Burciaga Flores | |
| Graciela Arelí López Uriarte | |||
| Liliana Nayeli Romero Gutiérrez | |||
| María Magdalena Medina Aguado | |||
| Víctor Manuel Torres de la Cruz | |||
| Viviana Maricela Gómez Puente | |||
| P2860 | cites work | Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma | Q27003962 |
| Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining. | Q30943859 | ||
| Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers | Q33279439 | ||
| Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma | Q33343496 | ||
| Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes | Q33395890 | ||
| Maternal plasma biomarkers for down syndrome: present and future | Q34331085 | ||
| Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13. | Q34570581 | ||
| Current estimate of Down Syndrome population prevalence in the United States | Q35653563 | ||
| The proteins of human chromosome 21. | Q35821700 | ||
| Genetics of recurrent miscarriage: challenges, current knowledge, future directions | Q35837851 | ||
| Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease. | Q36390685 | ||
| Quantitative proteomics characterization of a mouse embryonic stem cell model of Down syndrome | Q37154413 | ||
| Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain. | Q37613081 | ||
| Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome | Q37742084 | ||
| High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. | Q38032123 | ||
| Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis | Q38497910 | ||
| Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors | Q44274066 | ||
| [Identification of molecules with altered expression in the brain of mouse model for Down syndrome by comprehensive analyses]. | Q45906438 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening. | Q47673360 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| P433 | issue | 11 | |
| P921 | main subject | Down syndrome | Q47715 |
| pregnant person | Q104720811 | ||
| P304 | page(s) | 1483-1489 | |
| P577 | publication date | 2017-04-16 | |
| P1433 | published in | Journal of Maternal-Fetal and Neonatal Medicine | Q6295498 |
| P1476 | title | Proteomic profile of serum of pregnant women carring a fetus with Down syndrome using nano uplc Q-tof ms/ms technology | |
| P478 | volume | 31 |
Search more.